(NEW YORK)Shares of biotechnology company Celgene Corp. advanced Tuesday as a potential competitor to its bone-marrow cancer treatment in Europe failed a late-stage clinical trial.READ MORE
(NEW YORK)The Nasdaq 100 index rose Tuesday as shares of biopharmaceutical company Celgene Corp. advanced after competitor SuperGen Inc.'s bone marrow cancer drug Dacogen failed a late-s...READ MORE
Among the stock activity stories for Tuesday, July 1, from AP Financial News: NEW YORK (AP)--Shares of Capital One Financial Corp. rose Tuesday after an analyst upgraded the credit...READ MORE
(NEW YORK)The Standard & Poor's 500 declined in midday trading on Tuesday, with the biggest fall taken by shares of Fortune Brands Inc., after the company lowered its outlook.READ MORE
(NEW YORK)The Nasdaq 100 index rose slightly in midday trading Tuesday as the broader markets fluctuated and investors scrutinized a report showing fuel prices continue to lambast the manufa...READ MORE
(NEW YORK)SuperGen Inc. said Tuesday its bone marrow disorder drug Dacogen failed in a late-stage European clinical trial, which pressured SuperGen shares and boosted Celgene Corp., which ma...READ MORE
(NEW YORK)The Nasdaq 100 index slipped in midday trading Friday as the markets wobbled on record-high oil prices, a weak consumer sentiment reading and a government report showing personal s...READ MORE